The reciprocal negative interactions of melatonin and the GR, including via BAG-1, also modulate hypothalamic fluxes with consequences for cancer pathoetiology and dynamic intercellular interactions in the tumor microenvironment. This evidence concerns the gene NR3C1 and neoplasm.